Do you want to read an article? Please log in or register.
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures
Aging and Cognitive FunctionsMultiple Sclerosis
Related content
Aging and Cognitive FunctionsMultiple Sclerosis
Cognition in multiple sclerosis: Between cognitive reserve and brain volume
J Neurol Sci.
Fenu G, Lorefice L, Arru M, Sechi V, Loi L, Contu F, Cabras F, Coghe , Frau J, Fronza M, Sbrescia G, Lai V, Boi M, Mallus S, Murru S, Porcu A, Barracciu MA, Marrosu MG, Cocco E
doi: 10.1016/j.jns.2018.01.011.
RECOMMENDED
Multiple Sclerosis
Central Slab versus Whole Brain to Measure Brain Atrophy in Multiple Sclerosis
Eur Neurol.
Ruberte E, Sinnecker T, Amann M, Gaetano L, Naegelin Y, Penner IK, Kuhle J, Derfuss T, Kappos L, Granziera C, Wuerfel J, Yaldizli Ö
doi: 10.1159/000495798.
Multiple Sclerosis
Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment
J Neurol.
Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M
doi: 10.1007/s00415-018-9139-6.
Aging and Cognitive FunctionsMultiple Sclerosis
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study)
J Neurol.
Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group
doi: 10.1007/s00415-017-8642-5.
Multiple Sclerosis
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Brain
Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J
doi: 10.1093/brain/awy154.
RECOMMENDED
Aging and Cognitive FunctionsMultiple Sclerosis
Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis
Brain.
Brownlee WJ, Altmann DR, Prados F, Miszkiel KA, Eshaghi A, Gandini Wheeler-Kingshott CAM, Barkhof F, Ciccarelli O
doi: 10.1093/brain/awz156.
Aging and Cognitive FunctionsMultiple Sclerosis
Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
Lancet Neurol.
Chan D, Binks S, Nicholas JM, Frost C, Cardoso MJ, Ourselin S, Wilkie D, Nicholas R, Chataway J
doi: 10.1016/S1474-4422
RECOMMENDED
Multiple Sclerosis
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Mult Scler.
Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, Benedict RH
doi: 10.1177/1352458519881428.
Multiple Sclerosis
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
Brain.
Rocca MA, Sormani MP, Rovaris M, Caputo D, Ghezzi A, Montanari E, Bertolotto A, Laroni A, Bergamaschi R, Martinelli V, Comi G, Filippi M
doi: 10.1093/brain/awx250.